Comparative Pharmacology
Head-to-head clinical analysis: AQUATAG versus AQUATENSEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AQUATAG versus AQUATENSEN.
AQUATAG vs AQUATENSEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Benzthiazide is a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium, chloride, and water.
AQUATENSEN (methylclothiazide) is a thiazide diuretic that inhibits the sodium-chloride cotransporter (NCC) in the distal convoluted tubule of the nephron, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume and blood pressure.
25-100 mg orally once daily in the morning.
1-2 mg orally once daily, titrated to blood pressure response; maximum dose 4 mg/day.
None Documented
None Documented
Terminal elimination half-life: 2-3 hours (prolonged in renal impairment, e.g., up to 24 hours in anuria)
Terminal elimination half-life is 8-12 hours (mean 10 h); clinically, allows twice-daily dosing
Renal: ~95% as unchanged drug; biliary/fecal: ~5%
Renal: 50% unchanged; Fecal: 20% (via bile); remainder as inactive metabolites
Category C
Category C
Diuretic
Diuretic